The page is the record's research on the issuer — no analyst, no rating, no view. # Advanced Biomed Inc. (NASDAQ: ADVB) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Advanced Biomed Inc., listed on NASDAQ under ticker ADVB. ISIN US00752P2039; LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-NV). Security type Corporate; segment not on the record; sector 8071 Services-Medical Laboratories; jurisdiction United States, Nevada. Listing status: listed, not halted. ## The disclosure read The record holds 28 filings in the twelve months to 2026-11-08, across 26 filing days. The median gap between filing days is 13 days. The latest filing is dated 2026-10-13 and is of type results; it was 26 days before the record date. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. In the sector the median cadence gap is 5.5 days, the median filings count is 79, and the median latency is 3 days across 29 issuers. The issuer's cadence gap of 13 days is above the exchange median and above the sector median. Its filing count of 28 is below both medians. Its latency of 26 days is above both medians. Filings by type: ad hoc 2, AGM/EGM 2, corporate news 8, director change 1, directors' dealings 1, halt/suspension 1, regulatory filing 8, results 4, takeover 1. ## Auditor The auditor of record is WWC, P.C., located in San Mateo, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change: not on the record (EDGAR states no dated change of state of incorporation on a filing line). Segment move: not on the record (the exchanges' tier transfers are not EDGAR filings). Halt flag: listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. Rule version: acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1; chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with earliest sealed date 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001941029.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ADVB (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1941029/000121390026109029/ea0307457-10k_advanced.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ADVB (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ADVB · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp